[China Packaging Network News] China's packaging design has always been a relatively late development market, compared with the world's advanced level, China's packaging design market does not have much competitiveness. There are still many problems in China's pharmaceutical packaging design. Let's take a look at the problems in China's pharmaceutical packaging design. I hope we can learn from them and carry forward.
At present, the pharmaceutical packaging of some pharmaceutical companies in China still uses paper products that are prone to moisture and dust. However, the internationally advanced heat shrinkable film packaging has been used. This package has high strength, good transparency, good appearance, moisture resistance, dust resistance, and low cost. In the middle box packaging of 10 or 10 bottles of pharmaceuticals as an example, the heat shrinkable film packaging cost is 0.03 to 0.07 yuan each, and the carton cost is 0.5 to 2 yuan each. Nowadays, many of the domestically-made pharmaceutical tablets and capsules are bottle-shaped, and they can also be protected from light, moisture, and oxidation, but their technological content is not high. For the packaging of special medicines, PVC hard sheets and PVC/PE composite hard sheets are used to make blister packs for blister packs, which can prevent drugs from degrading mildew and extend the shelf life of medicines. In pharmaceutical glass packaging, there is a certain gap in the material of the glass. Internationally, pharmaceutical grade A grades are widely used in medical glass. This material is more stable in physical properties and can effectively protect the chemical properties of pharmaceuticals. Moreover, the broken surface of the broken bottle is smooth and free from subtle cracks. Joint ventures and large state-owned enterprises use a small amount of Grade A materials, but most companies still use Class B materials for pharmaceutical packaging.
According to the research on the international pharmaceutical packaging market, the focus of pharmaceutical packaging will change greatly in the coming years. In particular, container packaging will be diverted to cardboard boxes and blister packs, and bottle caps and bottle closures are also reduced due to the use of containers. The market share has declined. Labels and loose-leaf prints will become even more important. From a long-term perspective, more drugs will be sold in the form of drug delivery systems such as nasal sprays rather than injections. Many injectable products may also begin to be sold as needle-free injections. Although this does not increase the use of containers, the extra costs will help drive its market share growth. The market share of cardboard boxes may decline because this industry is unlikely to have greater technological advancement. The tremendous changes brought about by different printing methods are improving the appearance of the packaging. Part of it is to improve the company's image and help identify the product. The other part is more important for anti-counterfeiting needs. Such as near-infrared fluorophore stripe coding, time-sensitive, temperature-sensitive and even self-destructive smart ink, photosensitive ink, optically variable ink, UV aniline ink. Although these technologies have been studied in the pharmaceutical packaging industry in China, there is still a certain gap.
According to the editor of China Packaging Network, the development of the packaging market requires the support of packaging design. Although packaging design is not mature enough, as long as there is concern about the problems in the packaging market, I believe that it will be able to find a solution quickly when it is avoided. Methods.